Evidence map›Paper›PMID 29346347›Full record

ArticleMucosal immunology2018

CD103

A Flores-Langarica, K Müller Luda, E K Persson, C N Cook, S Bobat, J L Marshall, M W Dahlgren, K Hägerbrand, K M Toellner, M D Goodall and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Mucosal immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. SeaB is a conservedInfection and immunity · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Gut-associated IgANature communications · 2019
    Article
  18. Article
  19. Review
  20. Intestinal CD103Frontiers in immunology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

A Flores-LangaricaInstitute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
K Müller LudaImmunology Section, Lund University, Lund, Sweden.
E K PerssonImmunology Section, Lund University, Lund, Sweden.
C N CookInstitute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
S BobatInstitute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
J L MarshallInstitute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
M W DahlgrenImmunology Section, Lund University, Lund, Sweden.
K HägerbrandImmunology Section, Lund University, Lund, Sweden.
K M ToellnerInstitute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
M D GoodallInstitute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
D R WithersInstitute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
I R HendersonInstitute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
B Johansson LindbomImmunology Section, Lund University, Lund, Sweden.
A F CunninghamInstitute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
W W AgaceImmunology Section, Lund University, Lund, Sweden.
University of Birmingham · GBLund University · SETechnical University of Denmark · DK

Funding

Biotechnology and Biological Sciences Research Council BB/L009986/1Medical Research Council G1001390Wellcome Trust 110199/Z/15/Z
6 · The paper itself

Abstract

Antibody responses induced at mucosal and nonmucosal sites demonstrate a significant level of autonomy. Here, we demonstrate a key role for mucosal interferon regulatory factor-4 (IRF4)-dependent CD103

Indexed as

AnimalsAntigens, CDCD11b AntigenCells, CulturedDendritic CellsFlagellinImmunity, HumoralImmunoglobulin AImmunoglobulin Class SwitchingImmunoglobulin GIntegrin alpha4Integrin alpha ChainsIntegrin beta ChainsInterferon Regulatory Factor-4Interferon Regulatory Factor-8Interferon Regulatory Factorsalpha E integrinsAntigens, CDCD11b AntigenFlagellinImmunoglobulin AImmunoglobulin GIntegrin alpha4Integrin alpha Chainsintegrin beta7Integrin beta ChainsInterferon Regulatory Factor-4Interferon Regulatory Factor-8Interferon Regulatory Factors

Identifiers

PMID29346347
PMCPMC5912514
OpenAlexW2779698349

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.